- Home
- PEPG vs TORO Comparison
PEPG vs TORO Comparison
Compare PEPG & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- TORO
- Stock Information
- Founded
- PEPG 2018
- TORO 2022
- Country
- PEPG United States
- TORO Cyprus
- Employees
- PEPG N/A
- TORO N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- TORO Marine Transportation
- Sector
- PEPG Health Care
- TORO Consumer Discretionary
- Exchange
- PEPG Nasdaq
- TORO Nasdaq
- Market Cap
- PEPG 45.5M
- TORO 36.7M
- IPO Year
- PEPG 2022
- TORO N/A
- Fundamental
- Price
- PEPG $1.10
- TORO $2.15
- Analyst Decision
- PEPG Buy
- TORO
- Analyst Count
- PEPG 3
- TORO 0
- Target Price
- PEPG $7.67
- TORO N/A
- AVG Volume (30 Days)
- PEPG 261.3K
- TORO 462.5K
- Earning Date
- PEPG 08-07-2025
- TORO 08-11-2025
- Dividend Yield
- PEPG N/A
- TORO N/A
- EPS Growth
- PEPG N/A
- TORO N/A
- EPS
- PEPG N/A
- TORO 1.09
- Revenue
- PEPG N/A
- TORO $22,394,283.00
- Revenue This Year
- PEPG N/A
- TORO N/A
- Revenue Next Year
- PEPG N/A
- TORO N/A
- P/E Ratio
- PEPG N/A
- TORO $1.95
- Revenue Growth
- PEPG N/A
- TORO 0.40
- 52 Week Low
- PEPG $0.88
- TORO $1.70
- 52 Week High
- PEPG $19.30
- TORO $4.05
- Technical
- Relative Strength Index (RSI)
- PEPG 29.69
- TORO 54.37
- Support Level
- PEPG $1.10
- TORO $1.95
- Resistance Level
- PEPG $1.49
- TORO $2.52
- Average True Range (ATR)
- PEPG 0.10
- TORO 0.20
- MACD
- PEPG -0.04
- TORO -0.01
- Stochastic Oscillator
- PEPG 0.00
- TORO 42.98
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.